Navigation Links
3SBio Announces Investor Conference Schedule
Date:9/7/2010

3SBio Announces Investor Conference Schedule -- re> SHENYANG, China, Sept. 7 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Supplementary Medicine, Trade Show News Click to view news release full screen  

3SBio Announces Investor Conference Schedule

 

SHENYANG, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ("3SBio") (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products today announced its planned participation in the following investor conferences: Sep 9-10, 2010 Susquehanna Fourth Annual Beijing Management Summit Beijing Sep 13-14, 2010 Morgan Stanley Global Healthcare Conference NYC Oct 20-22, 2010 Citigroup Greater China Investor Conference Macau Nov 1-2, 2010 Goldman Sachs China Investment Frontier Conference Beijing Nov 3-5, 2010 Bank of America Merrill Lynch China Investment Summit Beijing Nov 9-11, 2010 Morgan Stanley Asia Pacific Summit 2010 Singapore

Please see http://bbs.3sbio.com/en/News/xShowInfo_nnn6.aspx?ID=65 for further updates.

About 3SBio Inc.

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 500 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see http://www.3SBio.com for more information.

For more information, please contact: Investor Contacts Bo Tan Chief Financial Officer 3SBio Inc. Tel: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: +852-8191-6991 Email: ir@3SBio.com
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
2. 3SBio Inc. Announces Results of Annual General Meeting
3. China-Biotics Announces September 20 Investor Day Schedule
4. AcuNetx Announces Change in Trading Status
5. Regeneron Announces Presentation at the Morgan Stanley Global Healthcare Conference
6. ForteBio Announces Launch of Protein G Biosensor for Use on Companys Octet® Instruments
7. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
8. Nutraceutical Leader Announces Internal Promotions of Key Personnel
9. United American Healthcare Corporation Announces Increase in Board Size and New Director Nominees
10. Ellman International Announces Executive Team Hire
11. Yongye International Announces RMB 400 Million Revolving Credit Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... March 1, 2017  Numotion, the nation,s leading provider ... of Tek RMD ("robotic mobilization device") by Matia Robotics ... RMD is a motorized standing movement device that offers ... wheelchair to complete everyday activities from a standing position. ... Tek RMD unassisted. Numotion is the exclusive distributor of ...
(Date:3/1/2017)... ... Research and Markets has announced the addition of the "Global ... The Global Infertility Therapy Partnering Terms and Agreements since ... entered into by the world,s leading healthcare companies. The ... are discovery or development stage whereby the licensee obtains a right ...
(Date:3/1/2017)... PRINCETON, N.J. , March 1, ... Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun ... today announced that several new analyses from Phase-1 ... and 2) of tildrakizumab, an investigational IL-23p19 inhibitor ... psoriasis, will be presented at the 2017 Annual ...
Breaking Medicine Technology:
(Date:3/1/2017)... ... March 01, 2017 , ... After a long period of indulging in holidays, ... cleanses and workouts top the detox categories, there is a rare yet successful way ... Gaynor Method’s Vital Lung Detox is an herbal-based formula designed to help cleanse people’s ...
(Date:3/1/2017)... ... March 01, 2017 , ... Cotton Incorporated and PurThread ... cotton knit and woven fabrics. , Retail brands and consumers alike continue ... feel of cotton. Cotton Incorporated has developed cotton-rich fabrics with PurThread that ...
(Date:3/1/2017)... Calif. (PRWEB) , ... March 01, 2017 , ... Award-winning ... has completed 25 medical mission trips in underdeveloped nations, averaging more than one trip ... 2016. An article on the website features the details of his charitable ...
(Date:3/1/2017)... ... 01, 2017 , ... MilfordMD Cosmetic Dermatology Surgery & Laser ... for treatments aimed at tightening skin and contouring the neck. MilfordMD’s “ Spring ... 30 percent off all Thermage face and body treatments. March at MilfordMD is ...
(Date:3/1/2017)... ... March 01, 2017 , ... “Letter of Love”: a tale ... Maria Teresa Hamilton, survivor of the Civil War in El Salvador, wife, mother, and ... age of fifteen. I dedicated myself to serve in very poor communities, and I ...
Breaking Medicine News(10 mins):